Skip to content
Acting Auditions – Lifestyle
Author:
Spago Nanomedical
Spago Nanomedical Presents Tumorad(R) Clinical Data at the International ANZSNM 2026 Conference
May 18, 2026
Notice To Annual General Meeting of Spago Nanomedical AB (PUBL)
May 11, 2026
Spago Nanomedical Interim Report January-March 2026
May 7, 2026
Spago Nanomedical’s Phase I/IIa study Tumorad-01 Meets a Primary Endpoint and Provides Further Visible Tumor Uptake
May 6, 2026
←
Previous Page
1
2